| Year |
Citation |
Score |
| 2022 |
Eshleman SH, Fogel JM, Halvas EK, Piwowar-Manning E, Marzinke MA, Kofron R, Wang Z, Mellors J, McCauley M, Rinehart AR, Clair MS, Adeyeye A, Hinojosa JC, Cabello R, Middelkoop K, et al. HIV RNA screening reduces integrase strand transfer inhibitor resistance risk in persons receiving long-acting cabotegravir for HIV prevention. The Journal of Infectious Diseases. PMID 36240386 DOI: 10.1093/infdis/jiac415 |
0.31 |
|
| 2022 |
Joseph KW, Halvas EK, Brandt LD, Patro SC, Rausch JW, Chopra A, Mallal S, Kearney MF, Coffin JM, Mellors JW. Deep Sequencing Analysis of Individual HIV-1 Proviruses Reveals Frequent Asymmetric Long Terminal Repeats. Journal of Virology. e0012222. PMID 35674431 DOI: 10.1128/jvi.00122-22 |
0.318 |
|
| 2020 |
Halvas EK, Joseph KW, Brandt LD, Guo S, Sobolewski MD, Jacobs JL, Tumiotto C, Bui JK, Cyktor JC, Keele BF, Morse GD, Bale MJ, Shao W, Kearney MF, Coffin JM, et al. HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus. The Journal of Clinical Investigation. PMID 33016926 DOI: 10.1172/JCI138099 |
0.343 |
|
| 2019 |
Patro SC, Brandt LD, Bale MJ, Halvas EK, Joseph KW, Shao W, Wu X, Guo S, Murrell B, Wiegand A, Spindler J, Raley C, Hautman C, Sobolewski M, Fennessey CM, et al. Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors. Proceedings of the National Academy of Sciences of the United States of America. PMID 31776247 DOI: 10.1073/Pnas.1910334116 |
0.405 |
|
| 2018 |
Veldkamp PJ, Mellors JW, Halvas EK. Should we be testing for baseline integrase resistance in patients newly diagnosed with human immunodeficiency virus? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29324987 DOI: 10.1093/Cid/Ciy015 |
0.309 |
|
| 2017 |
Van Zyl GU, Katusiime MG, Wiegand A, McManus WR, Bale MJ, Halvas EK, Luke B, Boltz VF, Spindler J, Laughton B, Engelbrecht S, Coffin JM, Cotton MF, Shao W, Mellors JW, et al. No evidence of HIV replication in children on antiretroviral therapy. The Journal of Clinical Investigation. PMID 28891813 DOI: 10.1172/Jci94582 |
0.312 |
|
| 2017 |
Bui JK, Halvas EK, Fyne E, Sobolewski MD, Koontz D, Shao W, Luke B, Hong FF, Kearney MF, Mellors JW. Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells. Plos Pathogens. 13: e1006230. PMID 28225830 DOI: 10.1371/Journal.Ppat.1006230 |
0.306 |
|
| 2011 |
Boltz VF, Zheng Y, Lockman S, Hong F, Halvas EK, McIntyre J, Currier JS, Chibowa MC, Kanyama C, Nair A, Owino-Ong'or W, Hughes M, Coffin JM, Mellors JW. Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine. Proceedings of the National Academy of Sciences of the United States of America. 108: 9202-7. PMID 21576473 DOI: 10.1073/Pnas.1105688108 |
0.304 |
|
| 2010 |
Halvas EK, Wiegand A, Boltz VF, Kearney M, Nissley D, Wantman M, Hammer SM, Palmer S, Vaida F, Coffin JM, Mellors JW. Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients. The Journal of Infectious Diseases. 201: 672-80. PMID 20102272 DOI: 10.1086/650542 |
0.32 |
|
| 2006 |
Halvas EK, Aldrovandi GM, Balfe P, Beck IA, Boltz VF, Coffin JM, Frenkel LM, Hazelwood JD, Johnson VA, Kearney M, Kovacs A, Kuritzkes DR, Metzner KJ, Nissley DV, Nowicki M, et al. Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. Journal of Clinical Microbiology. 44: 2612-4. PMID 16825395 DOI: 10.1128/Jcm.00449-06 |
0.426 |
|
| 2005 |
Nissley DV, Halvas EK, Hoppman NL, Garfinkel DJ, Mellors JW, Strathern JN. Sensitive phenotypic detection of minor drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants. Journal of Clinical Microbiology. 43: 5696-704. PMID 16272507 DOI: 10.1128/Jcm.43.11.5696-5704.2005 |
0.378 |
|
| 2005 |
Palmer S, Kearney M, Maldarelli F, Halvas EK, Bixby CJ, Bazmi H, Rock D, Falloon J, Davey RT, Dewar RL, Metcalf JA, Hammer S, Mellors JW, Coffin JM. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. Journal of Clinical Microbiology. 43: 406-13. PMID 15635002 DOI: 10.1128/Jcm.43.1.406-413.2005 |
0.351 |
|
| 2000 |
Halvas EK, Svarovskaia ES, Pathak VK. Role of murine leukemia virus reverse transcriptase deoxyribonucleoside triphosphate-binding site in retroviral replication and in vivo fidelity. Journal of Virology. 74: 10349-58. PMID 11044079 DOI: 10.1128/Jvi.74.22.10349-10358.2000 |
0.497 |
|
| 2000 |
Halvas EK, Svarovskaia ES, Freed EO, Pathak VK. Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2',3'-dideoxy-3'-thiacytidine. Journal of Virology. 74: 6669-74. PMID 10864683 DOI: 10.1128/Jvi.74.14.6669-6674.2000 |
0.477 |
|
| 2000 |
Halvas EK, Svarovskaia ES, Pathak VK. Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity. Journal of Virology. 74: 312-9. PMID 10590119 DOI: 10.1128/Jvi.74.1.312-319.2000 |
0.501 |
|
| Show low-probability matches. |